Efficacy and safety of enpatoran, a Toll-like receptor 7/8 inhibitor, in patients with skin manifestations of cutaneous lupus erythematosus or systemic lupus erythematosus: findings from Cohort A of a multicentre, international, double-blind, placebo-controlled, dose-finding phase 2 trial. - Morand EF; Werth VP; Wenzel J; Furie R; Dall'Era M; Sanchez-Guerrero J; Roy S; Goodson SG; Moreau F; Gühring H; Sgouroudi E; Klopp-Schulze L; et al. (The Lancet. Rheumatology, 2026)